Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000133 · ClinicalTrials.gov registry record · NA
Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity
A NA study of Retinopathy of Prematurity, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- NA
- Development phase
- 20
- Study locations
NCT00000133 is a NA study of Retinopathy of Prematurity that has completed, run by National Eye Institute (NEI). The trial reports 20 study locations across 16 states.
The verdict
NCT00000133, a NA study of Retinopathy of Prematurity, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- NA
- Development phase
- 20
- Study locations
Study Summary
To determine the safety and efficacy of trans-scleral cryotherapy of the peripheral retina in certain low birth-weight infants with retinopathy of prematurity (ROP) for reducing blindness from ROP. To determine the long-term outcome for eyes that had severe ("threshold") ROP, both with and without cryotherapy.
Conditions Studied
Interventions
- PROCEDURE Trans-scleral Cryotherapy
Study Locations (20)
District of Columbia
- Private practice of David Plotsky, MD - Washington D.C.
- Retina Group of Washington - Washington D.C.
Michigan
- Private practice of John D. Baker, MD - Dearborn
- Associated Retinal Consultants, P.C. - Royal Oak
Ohio
- Private Practice of Miles J. Burke, MD - Cincinnati
- Columbus Children's Hospital - Columbus
Pennsylvania
- Children's Hospital of Philadelphia, Division of Pediatric Ophthalmology - Philadelphia
- Pediatric Ophthalmology and Strabismus, Inc. - Pittsburgh
Alabama
- Alabama Ophthalmology Associates, P.C. - Birmingham
Florida
- Bascom Palmer Eye Institute, University of Miami School of Medicine - Miami
Illinois
- University of Illinois Eye and Ear Infirmary - Chicago
Indiana
- Department of Ophthalmology, Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Start Date | 1986-01 |
| Est. Completion | 2003-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000133
The ClinicalTrials.gov registry entry for NCT00000133 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinopathy of Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Trans-scleral Cryotherapy is the first listed.
NCT00000133 reports 20 study locations spanning 16 distinct geographic areas - top geographies include District of Columbia, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT00000133 about?
NCT00000133 is a clinical study titled "Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity". To determine the safety and efficacy of trans-scleral cryotherapy of the peripheral retina in certain low birth-weight infants with retinopathy of prematurity (ROP) for reducing blindness from ROP. To determine the long-term outcome for eyes that had severe ("threshold") ROP, both with and without ...
What is the current status of trial NCT00000133?
This trial is currently completed. It is a NA study. The study started on 1986-01. Estimated completion is 2003-08.
What conditions does trial NCT00000133 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity.
What interventions are being tested in trial NCT00000133?
The interventions under investigation include: Trans-scleral Cryotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT00000133?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000133 being conducted?
This trial has 20 study locations across Alabama, District of Columbia, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
RECRUITING · NA
-
Validation of i-ROP DL to Detect More Than Mild ROP
ACTIVE NOT RECRUITING · NA
-
Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids
COMPLETED · NA
-
Imaging Retinal Vasculature in Infant Eyes
RECRUITING
-
Clinical and Genetic Analysis of ROP
RECRUITING
-
Bevacizumab Treatment For Type 1 ROP
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.